Anticancer Therapies – News and Features

GenPath also offers CYP2D6 test for tamoxifen resistance, CYP2C9/VKORC1 test for warfarin metabolism, and UGT1A1 test for irinotecan toxicity.

Deforolimus is currently being studied in multiple clinical trials, both alone and in combination with other therapies.

Researchers find that cannabinoid cell surface receptor CB1 plays a tumor-suppressing role in human colorectal cancer.

Scientists have identified a mechanism by which dormant, metastatic tumor cells can begin growing again after long periods of inactivity.

The open-label dose ranging study, being conducted with the Prostate Cancer Clinical Trial Consortium will evaluate the safety, tolerance and pharmacokinetics of APOPTONE.

Discovery from Institute for Research in Immunology and Cancer at the Universite de Montreal could fight age-related decline in immune response.

The acquisition is expected to allow Rosetta Genomics to expedite development and validation of its microRNA-based diagnostic tests worldwide.

Syngene’s image analysis software is being used by scientists at GUMC to assess molecular mechanisms of novel pro-drugs on breast cancer cells.

The Company has acquired the rights to the newly discovered diagnostic test from Helsinki University Central Hospital through Licentia Ltd.

The Company has reached an agreement with the FDA on the design of a Phase 3 registration trial of OGX-011.